206-192-4

应用筛选条件

关键词:'206-192-4'

显示 1-2 共 2 条结果关于 "206-192-4" 范围论文

Comparison of effects of pitavastatin versus pravastatin on serum proprotein convertase subtilisin/kexin type 9 levels in statin-naive patients with coronary artery disease.

Tsuyoshi Nozue et al.

The American journal of cardiology, 111(10), 1415-1419 (2013-02-26)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of serum low-density lipoprotein cholesterol levels. Although statins increase serum PCSK9 levels, the effects of different types of statins on the serum PCSK9 levels have not been examined in detail.

[Interaction of mutations M235T of the gene for angiotensinogen and Taq I 8,000 in the gene for endothelin-1 at the onset of essential hypertension].

A Vasků et al.

Casopis lekaru ceskych, 139(15), 464-467 (2000-08-02)

Identification of mutations contributing to the pathogenesis of essential hypertension performs to understand deeper consequences of developing pathophysiological changes, to value individual risk of hypertension in the preclinical stages and, regarding the observed genotype, to choose optimum therapy. The aim

1/1